Effects of splenectomy and pancreatectomy for gastric cancer
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000007425
- Lead Sponsor
- Digestive Disease Center, Showa University Nothern Yokohama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) synchronous or metachronous malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival and relapse-free survival
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the impact of splenectomy on gastric cancer prognosis and immune response?
How does pancreatectomy compare to standard surgical approaches in gastric cancer treatment outcomes?
Are there specific biomarkers that predict survival benefits from splenectomy in gastric cancer patients?
What are the potential adverse events associated with splenectomy and pancreatectomy in gastric cancer trials?
What combination therapies are being explored alongside splenectomy and pancreatectomy for advanced gastric cancer?